Podchaser Logo
Home
109: Aurobindo's US outlook improves but earnings may just be steady

109: Aurobindo's US outlook improves but earnings may just be steady

Released Tuesday, 17th November 2020
Good episode? Give it some love!
109: Aurobindo's US outlook improves but earnings may just be steady

109: Aurobindo's US outlook improves but earnings may just be steady

109: Aurobindo's US outlook improves but earnings may just be steady

109: Aurobindo's US outlook improves but earnings may just be steady

Tuesday, 17th November 2020
Good episode? Give it some love!
Rate Episode

Investors are banking on Aurobindo’s US pharma revenues getting a boost on the back of improving injectable sales in the second quarter. But a part of that growth already seems to be reflecting in the stock price gains of about 86% in 2020. Find more details in this podcast. Listen in.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features